Technical Analysis for ABVC - ABVC Biopharma, Inc.

Grade Last Price % Change Price Change
D 2.48 -0.20% -0.01
ABVC closed down 0.2 percent on Friday, September 24, 2021, on 4 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Down
Historical ABVC trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -0.20%
Outside Day Range Expansion -0.20%
Wide Bands Range Expansion -0.20%
Oversold Stochastic Weakness -0.20%
Narrow Range Bar Range Contraction -3.88%
Wide Bands Range Expansion -3.88%
Older End-of-Day Signals for ABVC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 15 hours ago
Up 3% about 19 hours ago
Up 2% about 19 hours ago
Up 1% about 19 hours ago
Outside Day 1 day ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ABVC Biopharma, Inc. Description

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Pancreatic Cancer Depression Attention Deficit Hyperactivity Disorder Myelodysplastic Syndromes Triple Negative Breast Cancer Major Depressive Disorders Treatment Of Pancreatic Cancer

Is ABVC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.75
52 Week Low 1.955
Average Volume 2,573,142
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 2.99
10-Day Moving Average 2.67
Average True Range 0.36
ADX 37.17
+DI 29.55
-DI 15.69
Chandelier Exit (Long, 3 ATRs) 3.67
Chandelier Exit (Short, 3 ATRs) 3.45
Upper Bollinger Bands 3.76
Lower Bollinger Band 2.21
Percent B (%b) 0.17
BandWidth 51.75
MACD Line -0.08
MACD Signal Line 0.01
MACD Histogram -0.0892
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.65
Resistance 3 (R3) 2.67 2.63 2.62
Resistance 2 (R2) 2.63 2.59 2.62 2.61
Resistance 1 (R1) 2.56 2.56 2.54 2.54 2.60
Pivot Point 2.52 2.52 2.51 2.51 2.52
Support 1 (S1) 2.44 2.47 2.42 2.42 2.36
Support 2 (S2) 2.40 2.45 2.39 2.35
Support 3 (S3) 2.33 2.40 2.34
Support 4 (S4) 2.31